Raising awareness in healthcare professionals; defining clinical standards for detection and treatment; ongoing community support and a nationally coordinated sepsis body. Luregn Schlapbach introduces the Stopping Sepsis: National Action Plan to improve paediatric sepsis outcomes via systems and standards of care.
Luregn is Associate Professor at the University of Queensland and Senior Staff Specialist in the 36-bed multidisciplinary PICU at Queensland Children's Hospital in Brisbane. He is the medical lead of the Paediatric Critical Care Research Group (PCCRG) at the Child Health Research Centre. He holds a NHMRC Practitioner Fellowship on Sepsis, Infection, and Inflammation in Critically Ill Children and is current Chair of the ANZICS Paediatric Study Group. Luregn is group head on the Pediatric Surviving Sepsis Campaign, Co-Chair of the international Paediatric Sepsis Definition Taskforce, and the paediatric lead for the Queensland Sepsis Collaborative. He has been leading observational, genomic and interventional paediatric sepsis studies and is involved in international consortia on life-threatening childhood infections. Luregn is in the steering board of several NHMRC funded paediatric interventional trials. Luregn's research has focused on sepsis and life-threatening infections in critically ill neonates and children, including aspects such as epidemiology, sepsis markers, outcomes and genomics in this highly vulnerable patient group. He is interested in improving our understanding of why some children become critically unwell because of infections, and in developing better approaches to allow early recognition and targeted treatment of sepsis and severe infections in children.
From the 2019 APLS Paediatric Acute Care Conference in Perth.